Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
about
Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patientsAccuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review.Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failureB-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.Hormone therapy with tamoxifen reduces plasma levels of NT-B-type natriuretic peptide but does not change ventricular ejection fraction after chemotherapy in women with breast cancerNeuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the communityReduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifyllineIncreased formation of F(2)-isoprostanes in patients with severe heart failure.Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction.Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese populationNT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension.Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytesBrain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practiceB-type natriuretic peptide and its clinical implications in heart failure.Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart diseaseDiagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.B-type Natriuretic Peptide as an Index of Symptoms and Severity of Chronic Rheumatic Mitral Regurgitation.Relation between N-terminal pro-brain natriuretic peptide values and invasively measured left ventricular hemodynamic indicesCorrelation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failureA bioclinical pattern for the early diagnosis of cardioembolic stroke.Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic Peptide plasma levels.Predictors of unfavourable prognosis in chronic Chagas' disease.Atrial natriuretic peptide as a marker of heart failure in children with left ventricular volume overload.Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration.Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.Maximum longitudinal relaxation velocity of the left ventricle: its clinical value and relationship with NT-proBNP plasma levels in heart failure.Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors.Practical implications of current natriuretic peptide research.Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma.Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion.Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation
P2860
Q26826868-DB1E50C4-D291-4E8B-AF8A-E30DE9EE3000Q33227738-3977D947-81D5-422C-A92D-63172A569C90Q33830253-B2F2F481-BB7C-42FE-9E1D-A8D8A3B18F5AQ34161199-3C9FFEEC-00D5-47AD-A790-5A106E458074Q34297057-E7F9B1B4-B224-4445-B435-2CFF9F75C83BQ35062498-239E7DB1-7AAF-4770-9D2C-BE9F7D584094Q35370704-5D169EF1-7FA3-4CC2-8F4D-3AAF293A2F2EQ35376319-B172F20C-2244-4438-87C4-6FAFD41D9D1AQ35376406-5546E725-1328-4EDE-A8B6-AA0D8AD30C52Q35376458-A8B811A2-A22C-4720-AE1C-883F0F56587FQ35382191-1762927B-8055-4B55-A63E-617B8173C603Q35579682-AA426533-79AC-4AC6-A731-1E24102274E7Q35580797-185DBD44-3DC4-4920-853E-414F4A284573Q35581313-6FFBAC5B-862F-4DB4-B64F-3F0E1828EE26Q35742577-4399FC58-D6E7-4E54-9D86-9EFD54EA77ABQ35780260-D5A4E83A-F1A9-4FB9-8B5F-8F3332A970E6Q35843114-0E1CF178-2A26-4D35-BB35-B9364E0EE180Q35987017-EF310B9A-F5DA-4574-A34C-9ABFC955F0DBQ36694171-D1C0E550-D66D-4429-B98F-0C41456DC9B8Q36732168-59644E11-D33A-46B7-844B-59847E2E0CCCQ36934578-9B44676F-941C-47CF-9A74-44C722F9A21AQ37276402-A7C49918-7281-40BE-9CC7-3B1C6062F2CAQ37477161-CBAB1197-4DEF-4778-B0B8-52FA47B74A50Q37657775-0C7D8D64-F49D-4FE2-97E0-D662CD06367FQ41860676-085E4D37-980D-4DF1-A356-2AF00FDBD42DQ43871653-B65CC22C-85BD-4799-B5B2-E0EDD4C4902AQ46221733-F0ECCD6D-BA0A-4865-8B58-02F736531386Q48230690-8A4D431E-549B-47AE-8792-F4E48C991856Q48378465-E0C5E2A2-DF9B-48B4-A788-B6364E47B41FQ48468296-ED580C62-6996-4318-A954-795B22FD6730Q48566443-628CD81B-69FE-455A-83A4-1F8E3A2D65FDQ48612769-7D025F68-9F92-46F8-BD10-F86BA92FA1EBQ48624965-AC55D99C-7DFC-476B-A58C-5A262912B329Q48920667-38A0BD82-ADC2-4951-9AF0-625179E85D82Q53642625-C43AC14F-9CE3-4DF3-984F-DA277F3ECE45Q58071174-7918B0D4-A2D3-4147-A6D1-4858F0E0832B
P2860
Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Comparison of atrial natriuret ...... tricular systolic dysfunction.
@en
Comparison of atrial natriuret ...... tricular systolic dysfunction.
@nl
type
label
Comparison of atrial natriuret ...... tricular systolic dysfunction.
@en
Comparison of atrial natriuret ...... tricular systolic dysfunction.
@nl
prefLabel
Comparison of atrial natriuret ...... tricular systolic dysfunction.
@en
Comparison of atrial natriuret ...... tricular systolic dysfunction.
@nl
P2093
P1476
Comparison of atrial natriuret ...... tricular systolic dysfunction.
@en
P2093
P304
P356
10.1016/S0002-9149(97)89176-X
P407
P577
1996-04-01T00:00:00Z